The Brain-Computer Interface (BCI) field appears to be one of the hottest areas in med tech with startups emerging, investors pouring money into the space and companies accelerating their development programs. Across Europe, the U.S. and China, clinical trials underway are demonstrating that implanting the technology into the brain translates thoughts into action and can transform the lives of people with neurological disorders. Patients are walking again. Communicating again. Living their lives again. But there is a long, long road ahead and lots of challenges to surmount before BCI becomes standard in clinical care. Plus, there are questions about public health, ethics and national security, especially as there is a high likelihood that the technology could not only be deployed to cure diseases, but for military and other malicious purposes.

Have brain-computer interfaces finally arrived?

2026 marks critical turning point for BCI technology

Brain-computer interfaces are here but long road ahead

Next wave of BCI firms builds on pioneers to tackle challenges

Investors bet on transformative BCI tech for neuro disorders

Ascending BCI systems deepen national security, ethical concerns

Deep brain stimulation from the shallows: tomorrow’s BCI technology?

Videos:

Cortec CEO Frank Desiere

Inbrain CEO Carolina Aguilar

Ability Neurotech CEO Rotem Kopel

Axoft CEO Paul Le Floch